Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 3Phase 2 3Phase 4 1Phase 2/3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1

Conditions

Carcinoma, Hepatocellular 2Prostatic Neoplasms 1Disease 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × fluorocholine × Clear all
NCT04965454 2025-05-01

ExTRACT-HCC

Queen's Medical Center

Phase 2 Recruiting
80 enrolled
Gastrointestinal

Disease, Carcinoma, Hepatocellular

NCT02397408 2020-11-19

11C- and 18F-Choline PET/MR Imaging for Prostate Cancer

University of California, San Francisco

Phase 2 Completed
18 enrolled 21 charts
Genitourinary

Prostatic Neoplasms

NCT01395030 2018-09-26

PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

Queen's Medical Center

Phase 2 Completed
64 enrolled 13 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡